Acute Low-Tone Sensorineural Hearing Loss Presenting With Non-Rotatory Vestibular Prodrome in a High-Risk Patient: A Comprehensive Case Report on Aggressive Systemic Corticosteroid Management and Prognostic Evaluation

Authors

  • Marsella Lulu Aulia Tangerang City General Hospital, Tangerang, Banten, Indonesia
  • Gustav Syukrinto Tangerang City General Hospital, Tangerang, Banten, Indonesia

DOI:

https://doi.org/10.59141/-.v8i1.503

Keywords:

Acute Low-Tone Hearing Loss, Sudden Sensorineural Hearing Loss, Menière's Disease, High-Dose Corticosteroids

Abstract

Acute Low-Tone Hearing Loss (ALHL) is often recognized as the clinical manifestation of cochlear-restricted endolymphatic hydrops (EH), making it highly prone to recurrence and subsequent conversion into definitive Menière's Disease (MD). Given this risk, necessitate immediate and aggressive therapeutic intervention to stabilize inner ear function. This research aims to study the therapy and observation in patients with ALHL. Case Report A 27-year-old female presented with acute unilateral tinnitus, aural fullness and new-onset subtle, non-rotatory dizziness, unsteadiness and an episode of nausea and vomiting. Pure tone audiometry, showed a low tone sensorineural hearing loss. What do we have to consider in treatment of patient with ALHL to avoid worsening progression and achieve complete recovery? Literature research was carried out through PubMed and Google Scholar with keywords "Acute Low Tone Hearing Loss" AND "Sudden Sensorineural Hearing Loss" AND "Therapy". Based on the search, we found recommendations in managing patient of ALHL, such as high-dose corticosteroids, pure-tone audiometric evaluation, anti-hydrops agents, and other supportive management. There are several considerations in ALHL therapy in patients that should be carried out carefully and with comprehensive, prolonged audio vestibular surveillance.

Downloads

Download data is not yet available.

References

Alexander, T. H., & Harris, J. P. (2013). Incidence of sudden sensorineural hearing loss. Otology & Neurotology, 34(9), 1586–1589.

Basso, L., Boecking, B., Brueggemann, P., Pedersen, N. L., Canlon, B., Cederroth, C. R., et al. (2020). Gender-specific risk factors and comorbidities of bothersome tinnitus. Frontiers in Neuroscience, 14, 706.

Bramantyo, B., Alviandi, W., & Bashirudin, J. (2024). Buku pendidikan dasar ilmu kesehatan telinga hidung tenggorok-bedah kepala leher: Buku pertama (1st ed.). Media Aesculapius.

Bramantyo, B., & Bashirudin, J. (2012). Buku ajar ilmu kesehatan telinga hidung tenggorok kepala & leher (7th ed.). Universitas Indonesia Publishing.

Diao, T., Chen, Y., Jing, Y., & Ma, X. (2023). Clinical characteristics and prognosis of acute low-frequency hearing loss and ascending sensorineural sudden sensorineural hearing loss. Frontiers in Neuroscience, 16, 1076109. https://pmc.ncbi.nlm.nih.gov/articles/PMC9871897/

Fuse, T., Aoyagi, M., Funakubo, T., Sakakibara, A., & Yoshida, S. (2002). Short-term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid. ORL: Journal for Oto-Rhino-Laryngology and Its Related Specialties, 64(1), 6–10. https://pubmed.ncbi.nlm.nih.gov/11891390/

Hu, B., Chen, M., Chen, X., Zhao, D., Zheng, Q., Nie, G., et al. (2021). Effectiveness of salvage intratympanic dexamethasone treatment for refractory sudden sensorineural hearing loss classified by audiogram patterns. Acta Otolaryngologica, 141(5), 449–453. https://pubmed.ncbi.nlm.nih.gov/33645435/

Im, G. J., Kim, S. K., Choi, J., Song, J. J., Chae, S. W., & Jung, H. H. (2016). Analysis of audio-vestibular assessment in acute low-tone hearing loss. Acta Otolaryngologica, 136(7), 649–654.

Jin, M. C., Qian, Z. J., Cooperman, S. P., & Alyono, J. C. (2020). Trends in use and timing of intratympanic corticosteroid injections for sudden sensorineural hearing loss. Otolaryngology–Head and Neck Surgery, 164(2 Suppl), S52–S59.

Junicho, M., Aso, S., Fujisaka, M., & Watanabe, Y. (2008). Prognosis of low-tone sudden deafness: Does it inevitably progress to Ménière's disease? Acta Otolaryngologica, 128(3), 304–308.

Jung, A. R., Kim, M. G., Kim, S. S., Kim, S. H., & Yeo, S. G. (2016). Clinical characteristics and prognosis of low-frequency sensorineural hearing loss without vertigo. Acta Otolaryngologica, 136(2), 159–163.

Klemm, E., Deutscher, A., & Mosges, R. (2009). A present investigation of the epidemiology in idiopathic sudden sensorineural hearing loss. Laryngorhinootologie, 88(8), 524–527. https://pubmed.ncbi.nlm.nih.gov/19194837/

Li, T., Yu, W., Lei, W., Zong, S., & Xiao, H. (2025). Targeting inflammation to prevent and treat sensorineural hearing loss. Chinese Medical Journal, 138(10), 1248–1250.

Lopez-Escamez, J. A., Carey, J., Chung, W. H., Goebel, J. A., Magnusson, M., Mandalà, M., et al. (2015). Diagnostic criteria for Ménière's disease. Journal of Vestibular Research, 25(1), 1–7. https://pubmed.ncbi.nlm.nih.gov/25882471/

Miwa, T., Yamaguchi, T., Kita, S., Osaka, K., Kanai, R., Maetani, T., et al. (2022). Predictive factors of acute sensorineural hearing loss in adult Japanese patients for clinical application by primary care doctors: A cross-sectional study. BMC Primary Care, 23(1), 219.

Nakashima, T., Sato, H., Gyo, K., Hato, N., Yoshida, T., Shimono, M., et al. (2014). Idiopathic sudden sensorineural hearing loss in Japan. Acta Otolaryngologica, 134(11), 1118–1123.

Rahman, M. T., Bailey, E. M., Gansemer, B. M., Pieper, A. A., Manak, J. R., & Green, S. H. (2023). Anti-inflammatory therapy protects spiral ganglion neurons after aminoglycoside antibiotic-induced hair cell loss. Neurotherapeutics, 20(2), 578–601.

Roh, K. J., Lee, E. J., Park, A. Y., Choi, B. I., & Son, E. J. (2015). Long-term outcomes of acute low-tone hearing loss. Journal of Audiology & Otology, 19(2), 74–78.

Shin, S. H., Byun, S. W., Park, S., Kim, E. H., Kim, M. W., & Lee, H. Y. (2021). Optimal first-line therapy for acute low-tone sensorineural hearing loss. Journal of Audiology & Otology, 25(4), 209–216.

Stölzel, K., Droste, J., Voß, L. J., Olze, H., & Szczepek, A. J. (2018). Comorbid symptoms occurring during acute low-tone hearing loss (ALHL) as potential predictors of Ménière's disease. Frontiers in Neurology, 9, 884. https://pubmed.ncbi.nlm.nih.gov/30420828/

Taki, M., Hasegawa, T., Ninoyu, Y., Mohri, H., & Hirano, S. (2021). Low-frequency sensorineural hearing loss associated with iron-deficiency anemia. Journal of International Advanced Otology, 17(5), 465–467. https://pmc.ncbi.nlm.nih.gov/articles/PMC8975401/

Thai-Van, H., Bounaix, M. J., & Fraysse, B. (2001). Ménière's disease: Pathophysiology and treatment. Drugs, 61(8), 1089–1102.

Yamasoba, T., Kikuchi, S., Sugasawa, M., Yagi, M., & Harada, T. (1994). Acute low-tone sensorineural hearing loss without vertigo. Archives of Otolaryngology–Head & Neck Surgery, 120(5), 532–535.

Downloads

Published

2026-04-14

How to Cite

Aulia, M. L., & Syukrinto, G. (2026). Acute Low-Tone Sensorineural Hearing Loss Presenting With Non-Rotatory Vestibular Prodrome in a High-Risk Patient: A Comprehensive Case Report on Aggressive Systemic Corticosteroid Management and Prognostic Evaluation. Jurnal Sehat Indonesia (JUSINDO), 8(1), 267–274. https://doi.org/10.59141/-.v8i1.503